학술논문
Isoliquiritigenin reduces experimental autoimmune prostatitis by facilitating Nrf2 activation and suppressing the NLRP3 inflammasome pathway
Document Type
Article
Author
Source
In Molecular Immunology May 2024 169:37-49
Subject
Language
ISSN
0161-5890